Maguy H. Hamie
Beirut, BA, Lebanon
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The Novel Imiqualine EAPB02303 Is a Potent Drug for Treating Acute Myeloid Leukemia.
Journal: Biomolecules
Published: March 25, 2025
Retinoic acid disrupts an NPM1c/ROS/SENP3/ARF oncogenic axis in acute myeloid leukemia.
Journal: Leukemia
Published: March 19, 2025
Invasion of Toxoplasma gondii bradyzoites: Molecular dissection of the moving junction proteins and effective vaccination targets.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 24, 2023
The Toxoplasma rhoptry protein ROP55 is a major virulence factor that prevents lytic host cell death.
Journal: Nature communications
Published: October 24, 2022
HAS 1: A natural product from soil-isolated Streptomyces species with potent activity against cutaneous leishmaniasis caused by Leishmania tropica.
Journal: Frontiers in pharmacology
Published: August 19, 2022
EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML.
Journal: International journal of molecular sciences
Published: February 15, 2022
Toxoplasmosis: Current and Emerging Parasite Druggable Targets.
Journal: Microorganisms
Published: October 27, 2021
Comprehensive Overview of Toxoplasma gondii-Induced and Associated Diseases.
Journal: Pathogens (Basel, Switzerland)
Published: September 14, 2021
P18 (SRS35/TgSAG4) Plays a Role in the Invasion and Virulence of Toxoplasma gondii.
Journal: Frontiers in immunology
Published: December 17, 2020
Imiquimod Targets Toxoplasmosis Through Modulating Host Toll-Like Receptor-MyD88 Signaling.
Journal: Frontiers in immunology
Published: November 17, 2020
Last Updated: 09/26/2026